Australia markets closed
  • ALL ORDS

    6,986.80
    +4.10 (+0.06%)
     
  • ASX 200

    6,715.40
    +0.10 (+0.00%)
     
  • AUD/USD

    0.7708
    -0.0071 (-0.91%)
     
  • OIL

    52.04
    -1.53 (-2.86%)
     
  • GOLD

    1,827.70
    -23.70 (-1.28%)
     
  • BTC-AUD

    46,931.75
    -439.40 (-0.93%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • AUD/EUR

    0.6376
    -0.0021 (-0.32%)
     
  • AUD/NZD

    1.0798
    +0.0028 (+0.26%)
     
  • NZX 50

    13,024.69
    -91.18 (-0.70%)
     
  • NASDAQ

    12,803.93
    -94.76 (-0.73%)
     
  • FTSE

    6,735.71
    -66.25 (-0.97%)
     
  • Dow Jones

    30,814.26
    -177.26 (-0.57%)
     
  • DAX

    13,787.73
    -200.97 (-1.44%)
     
  • Hang Seng

    28,573.86
    +77.00 (+0.27%)
     
  • NIKKEI 225

    28,519.18
    -179.08 (-0.62%)
     

Plasma Fractionation Market to Reach $41.4 Billion by 2027, Growing at a CAGR of 7% From 2020 With COVID-19 Impact - Meticulous Research® Analysis

Meticulous Market Research Pvt. Ltd.
·5-min read

Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) - Forecast to 2027

London, Jan. 14, 2021 (GLOBE NEWSWIRE) -- In its latest publication, titled Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) - Forecast to 2027”, Meticulous Research® states that the plasma fractionation market is expected to grow at a CAGR of 7% from 2020 to 2027 to reach $41.4 billion by 2027.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Plasma fractionation is a method of separating various components of blood plasma into its different components. Plasma-derived products are used in the prevention and treatment of life-threatening diseases caused by trauma, immunologic disorders, and infections.

The rising use of immunoglobulins in therapeutic areas, increasing number of chronic diseases, growing prevalence of blood and respiratory disorders, and rising number of plasma collection centers are some of the major factors driving the global plasma fractionation market.

To provide efficient analysis, Meticulous Research® has segmented this market by product [immunoglobulins (IVIG, SCIG, and others), coagulation factors, albumin, protease inhibitors, and others], application (immunology, hematology, neurology, critical care, hemato-oncology, rheumatology, and others), end user (hospitals & clinics, clinical research laboratories, and academic institutes) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5117

Geographically, in 2020, North America commanded the largest share of the global plasma fractionation market, followed by Europe and Asia-Pacific. However, APAC countries—China and Japan are slated to register the highest growth during the forecast period primarily due to factors, such as increasing prevalence of hemophilia and rising use of plasma-derived products, such as albumin and immunoglobulin.

On the basis of product, the immunoglobulins segment accounted for the largest share of the overall plasma fractionation market in 2020. The rising adoption of immunoglobulins for treating illness, such as autoimmune, primary & secondary immunological diseases, and neurological diseases is one of the major factors driving the growth of this segment.

On the basis of application, the neurology segment accounted for the largest share of the overall plasma fractionation market. Factors influencing the growth of this segment include rising incidence of neurological disorders and increasing geriatric population.

Quick Buy – Plasma Fractionation Market Research Report: https://www.meticulousresearch.com/Checkout/68317165

On the basis of end user, the hospitals & clinics segment accounted for the largest share of the overall plasma fractionation market in 2020. Factors driving the growth of this segment include the wide presence of hospitals in both urban & rural areas, improved infrastructure, and healthcare facilities provided by hospitals, along with increasing off-label use of plasma fractionated products in hospitals to treat various diseases.

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market, including CSL Limited (Australia), Grifols, S.A. (Spain), Octopharma AG (Switzerland), Kedrion S.P.A. (Italy), Shire plc (U.K.), Biotest AG (Germany), China Biologic Products Holdings, Inc. (China), Bio Products Laboratory Ltd (U.K.), Japan Blood Products Organization (Japan), and Shanghai RAAS Blood Products Co., Ltd. (China).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-fractionation-market-5117

Scope of the Report:

Plasma Fractionation Market, by Product

  • Immunoglobulins

    • Intravenous Immunoglobulins

    • Subcutaneous Immunoglobulins

    • Others

  • Coagulation Factors

  • Albumin

  • Protease Inhibitors

  • Others

Plasma Fractionation Market, by Application

  • Immunology

  • Hematology

  • Neurology

  • Critical Care

  • Hemato-Oncology

  • Rheumatology

  • Others

Plasma Fractionation Market, by End User

  • Hospitals& Clinics

  • Clinical Research Laboratories

  • Academic Institutes

Plasma Fractionation Market, by Geography

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • France

    • U.K.

    • Italy

    • Spain

    • Rest of Europe (RoE)

  • Asia-Pacific (APAC)

    • China

    • Japan

    • India

    • Rest of APAC (RoAPAC)

  • Latin America

  • Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Amidst this crisis, Meticulous Research® is continuously assessing the impact of the COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research

Related Reports-

Urinalysis Market by Product (Pregnancy and Fertility Test, Dipstick, Reagent, Automatic, Semi-automatic, and POC Analyzer), Application (Pregnancy, Diabetes, Kidney Disease, UTI), End-user (Hospitals and Clinics, Laboratory, Home Care) - Forecast to 2027

https://www.meticulousresearch.com/product/urinalysis-market-5089

Hemodialysis and Peritoneal Dialysis Market by Product (Machines, Dialyzers, Bloodlines, Catheters, Concentrates), Type (Conventional, Daily, Nocturnal), and End User (Hospital, Clinics and Dialysis Centers, and Home Use) - Global Forecast to 2027

https://www.meticulousresearch.com/product/the-hemodialysis-and-peritoneal-dialysis-market-5137

Plasmapheresis Market Size by Product Type (Instruments and Disposables), by Technology (Centrifugation and Membrane Filtration), by Application (Therapeutic Plasmapheresis and Source Plasma Collection), by End User (Biopharmaceutical Companies, Hospitals and Clinics, Others) - Global Forecasts to 2022

https://www.meticulousresearch.com/product/plasmapheresis-market-3092

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/366/plasma-fractionation-market-2027

CONTACT: Mr. Khushal Bombe Meticulous Research® Email- sales@meticulousresearch.com